Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / 2021 - Page 17

Year: 2021

WHO recommended interleukin-6 receptor blockers for COVID-19 and urged producers to join efforts to rapidly increase access
COVID-19 | Life Science History | WHO

WHO recommended interleukin-6 receptor blockers for COVID-19 and urged producers to join efforts to rapidly increase access

On Jul. 6, 2021, the World Health Organization announced updated patient care guidelines to include interleukin-6 receptor blockers,…

Read More WHO recommended interleukin-6 receptor blockers for COVID-19 and urged producers to join efforts to rapidly increase accessContinue

Dynavax and Biological E announced agreement of Dynavax’s CpG 1018 adjuvant for Biological E’s COVID-19 vaccine candidate
COVID-19 | Life Science History | Vaccine

Dynavax and Biological E announced agreement of Dynavax’s CpG 1018 adjuvant for Biological E’s COVID-19 vaccine candidate

On Jul. 6, 2021, Dynavax Technologies and Biological E announced the execution of a commercial supply agreement of…

Read More Dynavax and Biological E announced agreement of Dynavax’s CpG 1018 adjuvant for Biological E’s COVID-19 vaccine candidateContinue

Becton Dickinson and CerTest teamed up to detect covid-19 in saliva
Life Science History

Becton Dickinson and CerTest teamed up to detect covid-19 in saliva

On Jul. 5, 2021, CerTest Biotec and BD announces addition of saliva to the CE Marked VIASURE SARS-CoV-2…

Read More Becton Dickinson and CerTest teamed up to detect covid-19 in salivaContinue

NIH COVID-19 testing initiative funded additional research projects to safely return children to in-person school
Life Science History

NIH COVID-19 testing initiative funded additional research projects to safely return children to in-person school

On Jul. 2, 2021, the National Institutes of Health funding five additional projects to identify ways of safely…

Read More NIH COVID-19 testing initiative funded additional research projects to safely return children to in-person schoolContinue

U.S. FDA authorized an EUA for the Janssen COVID-19 vaccine manufacture at Emergent facility
COVID-19 | FDA | Life Science History

U.S. FDA authorized an EUA for the Janssen COVID-19 vaccine manufacture at Emergent facility

On Jul. 2, 2021, the Food and Drug Administration (FDA) authorized the use, under the emergency use authorization…

Read More U.S. FDA authorized an EUA for the Janssen COVID-19 vaccine manufacture at Emergent facilityContinue

Moderna announced Recipharm site in France manufacturing COVID-19 Vaccine following approval by EMA
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced Recipharm site in France manufacturing COVID-19 Vaccine following approval by EMA

On Jul. 1, 2021, Moderna confirmed that following the European Medicines Agency’s (EMA) Committee for Human Medicines (CHMP)…

Read More Moderna announced Recipharm site in France manufacturing COVID-19 Vaccine following approval by EMAContinue

HDT Bio received notice to proceed from FDA for U.S. phase 1 clinical trial of RNA COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

HDT Bio received notice to proceed from FDA for U.S. phase 1 clinical trial of RNA COVID-19 vaccine

On Jul. 1, 2021, HDT Bio announced the U.S. Food and Drug Administration had reviewed the companyメs Investigational…

Read More HDT Bio received notice to proceed from FDA for U.S. phase 1 clinical trial of RNA COVID-19 vaccineContinue

Ateaメs AT-527 oral antiviral drug candidate reduced viral replication in hospitalized patients with COVID-19
COVID-19 | Life Science History

Ateaメs AT-527 oral antiviral drug candidate reduced viral replication in hospitalized patients with COVID-19

On Jun. 30, 2021, Atea Pharmaceuticals announced positive interim results from the global Phase 2 study evaluating AT-527…

Read More Ateaメs AT-527 oral antiviral drug candidate reduced viral replication in hospitalized patients with COVID-19Continue

NIH-funded screening study builds case for frequent COVID-19 antigen testing
Biotechnology | COVID-19 | Diagnostics | NIH

NIH-funded screening study builds case for frequent COVID-19 antigen testing

On Jun. 30, 2021, the National Institutes of Health announced a highly anticipated study that compared rapid antigen…

Read More NIH-funded screening study builds case for frequent COVID-19 antigen testingContinue

CureVac announced final data from phase 2b/3 trial of first-generation COVID-19 vaccine candidate, CVnCoV
COVID-19 | Life Science History | Vaccine

CureVac announced final data from phase 2b/3 trial of first-generation COVID-19 vaccine candidate, CVnCoV

On Jun. 30, 2021, CureVac announced results from the final analysis of its 40,000 subject international pivotal Phase…

Read More CureVac announced final data from phase 2b/3 trial of first-generation COVID-19 vaccine candidate, CVnCoVContinue

Investigational malaria vaccine gives strong, lasting protection
Life Science History | Vaccine

Investigational malaria vaccine gives strong, lasting protection

On Jun. 30, 2021, the National Institutes of Health announced that two U.S. Phase 1 clinical trials of…

Read More Investigational malaria vaccine gives strong, lasting protectionContinue

From 30 million cases to zero: China certified malaria-free by WHO
WHO

From 30 million cases to zero: China certified malaria-free by WHO

On Jun. 30, 2021, following a 70-year effort, China was awarded a malaria-free certification from the World Health…

Read More From 30 million cases to zero: China certified malaria-free by WHOContinue

XPhyto supplied 10 test centers in Berlin with 25-minute COVID-19 PCR test
COVID-19 | Life Science History

XPhyto supplied 10 test centers in Berlin with 25-minute COVID-19 PCR test

On Jun. 30, 2021, XPhyto announced that it had signed a master supply agreement with Beovita and Tackleberries,…

Read More XPhyto supplied 10 test centers in Berlin with 25-minute COVID-19 PCR testContinue

Novavax published results of UK phase 3 clinical trial demonstrating high levels of COVID-19 vaccine efficacy
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Novavax published results of UK phase 3 clinical trial demonstrating high levels of COVID-19 vaccine efficacy

On Jun. 30, 2021, Novavax announced the publication of results from the final analysis of a pivotal Phase…

Read More Novavax published results of UK phase 3 clinical trial demonstrating high levels of COVID-19 vaccine efficacyContinue

SIGA supplied TPOXX (Tecovirimat) as compassionate treatment for Monkeypox case in the UK
Biotechnology | Therapeutics

SIGA supplied TPOXX (Tecovirimat) as compassionate treatment for Monkeypox case in the UK

On Jun. 30, 2021, SIGA Technologies announced that it had provided TPOXX (tecovirimat) to Liverpool University Hospitals NHS…

Read More SIGA supplied TPOXX (Tecovirimat) as compassionate treatment for Monkeypox case in the UKContinue

Gavi signed agreement with Clover Biopharmaceuticals for supply to COVAX
COVID-19 | Life Science History | Vaccine

Gavi signed agreement with Clover Biopharmaceuticals for supply to COVAX

On Jun. 30, 2021, Gavi, the Vaccine Alliance, that it had signed an advance purchase agreement with Clover…

Read More Gavi signed agreement with Clover Biopharmaceuticals for supply to COVAXContinue

Fostamatinib selected for NIH ACTIV-4 COVID-19 clinical trial
COVID-19 | Life Science History | NIH

Fostamatinib selected for NIH ACTIV-4 COVID-19 clinical trial

On Jun. 29, 2021, Rigel Pharma announced that fostamatinib, the Company’s novel oral spleen tyrosine kinase (SYK) inhibitor,…

Read More Fostamatinib selected for NIH ACTIV-4 COVID-19 clinical trialContinue

Adjuvant developed with NIH funding enhanced efficacy of Indiaメs COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

Adjuvant developed with NIH funding enhanced efficacy of Indiaメs COVID-19 vaccine

On Jun. 29, 2021, the National Institutes of Health announced that an adjuvant developed with its funding had…

Read More Adjuvant developed with NIH funding enhanced efficacy of Indiaメs COVID-19 vaccineContinue

Paratek announced first BARDA Project BioShield procurement of NUZYRA (omadacycline)
Biotechnology | Infectious Disease | Vaccine

Paratek announced first BARDA Project BioShield procurement of NUZYRA (omadacycline)

On Jun. 29, 2021, Paratek Pharmaceuticals announced it had delivered the first procurement of NUZYRA to the Biomedical…

Read More Paratek announced first BARDA Project BioShield procurement of NUZYRA (omadacycline)Continue

Moderna provides a clinical update on neutralizing activity of COVID-19 vaccine on emerging variants
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna provides a clinical update on neutralizing activity of COVID-19 vaccine on emerging variants

On Jun. 29, 2021, Moderna announced new results from in vitro neutralization studies of sera from individuals vaccinated…

Read More Moderna provides a clinical update on neutralizing activity of COVID-19 vaccine on emerging variantsContinue

Moderna announces Emergency Use Authorization for its COVID-19 vaccine granted by Government of India
Biotechnology | COVID-19 | Infectious Disease | Vaccine | WHO

Moderna announces Emergency Use Authorization for its COVID-19 vaccine granted by Government of India

On Jun. 29, 2021, Moderna announced that the government of India had issued a registration certificate and a…

Read More Moderna announces Emergency Use Authorization for its COVID-19 vaccine granted by Government of IndiaContinue

Altimmune announced update on AdCOVIDル phase 1 clinical trial
Life Science History | Vaccine

Altimmune announced update on AdCOVIDル phase 1 clinical trial

On Jun. 29, 2021, Altimmune announced phase 1 AdCOVID clinical trial data that showed AdCOVID appeared to be…

Read More Altimmune announced update on AdCOVIDル phase 1 clinical trialContinue

VBI Vaccines announced initial positive phase 1 data for its eVLP vaccine candidate against COVID-19
COVID-19 | Life Science History | Vaccine

VBI Vaccines announced initial positive phase 1 data for its eVLP vaccine candidate against COVID-19

On Jun. 29, 2021, VBI Vaccines announced positive Phase 1 data from its Phase 1/2 trial of the…

Read More VBI Vaccines announced initial positive phase 1 data for its eVLP vaccine candidate against COVID-19Continue

First trial participants vaccinated with Oxford COVID-19 variant vaccine
COVID-19 | Life Science History | Vaccine

First trial participants vaccinated with Oxford COVID-19 variant vaccine

On Jun. 28, 2021, the University of Oxford in partnership with AstraZeneca began vaccinations for a new phase…

Read More First trial participants vaccinated with Oxford COVID-19 variant vaccineContinue

Mixed Oxford/Pfizer vaccine schedules generated robust immune response against COVID-19
Biotechnology | COVID-19 | Vaccine

Mixed Oxford/Pfizer vaccine schedules generated robust immune response against COVID-19

On Jun. 28, 2021, researchers running the University of Oxford-led Com-COV study reported that alternating doses of the…

Read More Mixed Oxford/Pfizer vaccine schedules generated robust immune response against COVID-19Continue

Meridian resubmitted application to FDA for Emergency Use Authorization for Revogeneᆴ SARS-CoV-2 molecular assay
FDA | Life Science History

Meridian resubmitted application to FDA for Emergency Use Authorization for Revogeneᆴ SARS-CoV-2 molecular assay

On Jun. 28, 2021, Meridian Bioscience announced that it had re-submitted its application for Emergency Use Authorization (EUA)…

Read More Meridian resubmitted application to FDA for Emergency Use Authorization for Revogeneᆴ SARS-CoV-2 molecular assayContinue

COVID-19 PPE distribution
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Genomics | Life Science History | Medicine | Therapeutics | U.S. Congress | Vaccine

COVID-19 PPE distribution

Cast of Characters: Jay Inslee, Governor, Washington | Gavin Newsom, Governor, California | Doug Ducey, Governor, Arizona |…

Read More COVID-19 PPE distributionContinue

Rocheメs Actemra/RoActemra received FDA EUA for treatment of COVID-19 in hospitalised adults and children
COVID-19 | FDA | Life Science History

Rocheメs Actemra/RoActemra received FDA EUA for treatment of COVID-19 in hospitalised adults and children

On Jun. 25, 2021, Roche announced that the Food and Drug Administration (FDA) has issued an Emergency Use…

Read More Rocheメs Actemra/RoActemra received FDA EUA for treatment of COVID-19 in hospitalised adults and childrenContinue

Oxford researchers identified levels of antibody protection required to prevent symptomatic COVID-19
COVID-19 | Life Science History | Vaccine

Oxford researchers identified levels of antibody protection required to prevent symptomatic COVID-19

On Jun. 24, 2021, researchers from the University of Oxford released their findings about the so-called ムcorrelates of…

Read More Oxford researchers identified levels of antibody protection required to prevent symptomatic COVID-19Continue

NIH began sudy of COVID-19 vaccination during pregnancy and postpartum
COVID-19 | Life Science History | Vaccine

NIH began sudy of COVID-19 vaccination during pregnancy and postpartum

On Jun. 23, 2021, the National Institutes of Health announced that an observational study had begun to evaluate…

Read More NIH began sudy of COVID-19 vaccination during pregnancy and postpartumContinue

Page navigation

Previous PagePrevious 1 … 15 16 17 18 19 … 40 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search